Advertisement
Canada markets open in 3 hours 35 minutes

  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CAD/USD

    0.7249
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    85.00
    -0.41 (-0.48%)
     

  • Bitcoin CAD

    87,267.79
    -4,826.41 (-5.24%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,386.90
    +3.90 (+0.16%)
     

  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     

  • 10-Yr Bond

    4.6280
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,855.00
    -21.25 (-0.12%)
     

  • VOLATILITY

    19.23
    0.00 (0.00%)
     

  • FTSE

    7,847.90
    -117.63 (-1.48%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6819
    -0.0005 (-0.07%)
     
MARKETS LIVE BLOG:

STOCKS SLIP WITH MIDEAST TENSIONS, EARNINGS IN PLAY

Oil pares losses as traders anticipate Israel's response to Iranian attack

Company News for Jul 12, 2019

Zacks Equity Research

  • Shares of Cigna Corporation CI rose 9.2% after the Trump administration decided to scrap its drug rebate plan

  • Delta Air Lines, Inc.’s DAL shares increased 1.2% after the air transportation provider reported 8.7% revenue growth to $12.5 billion in Q2 from a year ago

  • Shares of Bed Bath & Beyond Inc. BBBY dropped 3% after the home goods retailer reported hefty losses because of $401 million in impairment charges in the fiscal first-quarter

  • Fastenal Company’s FAST shares dropped 2.9% after its Q2 earnings of $0.36 per share missed the Zacks Consensus Estimate of $0.37 per share


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
Fastenal Company (FAST) : Free Stock Analysis Report
 
Cigna Corporation (CI) : Free Stock Analysis Report
 
Bed Bath & Beyond Inc. (BBBY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research